Results 241 to 250 of about 31,663 (297)

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

Arthritis Care &Research, EarlyView.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall, Cinthia Blat, Eric Roberts, Jean W. Liew, Katherine Wysham, Namrata Singh, Janna Friedly, Lianne S. Gensler, Gabriela Schmajuk, Jinoos Yazdany   +9 more
wiley   +1 more source

Pharmaceutical governance system for costly drugs through human rights due diligence. [PDF]

BMJ
Lemmens T, Ghimire KM, Perehudoff K, Kohler JC, Low E, Persaud N.   +5 more
europepmc   +1 more source

The case for mandatory reporting to enable targets for healthy and environmentally sustainable food: means, motive and opportunity. [PDF]

BMC Med
Pechey R, Bandy L, Jebb SA.
europepmc   +1 more source

The impact of CEOs' academic backgrounds on corporate financialization. [PDF]

PLoS One
Qi B, Hu F, Zhang C.
europepmc   +1 more source

Commercial determinants of health-a scoping review of research 'made in Germany'. [PDF]

Eur J Public Health
Sell K, Nigg S, Leibinger A, Voss S, Klinger C, Rehfuess E.   +5 more
europepmc   +1 more source

Quarterly financial statements Data for Russian firms. [PDF]

Data Brief
Marakueva M, Popova P.
europepmc   +1 more source

Mind the (gender pay) gap: the role of board gender composition. [PDF]

J Popul Econ
Galanakis Y, Gosling A.
europepmc   +1 more source

2005 Corporate Social Responsibility Report

, 2005
openaire   +2 more sources

Corporate social responsibility reporting

, 2018
openaire   +1 more source